522 related articles for article (PubMed ID: 26514469)
21. Association of circulating resistin, leptin, adiponectin and visfatin levels with Behçet disease: a meta-analysis.
Lee YH; Song GG
Clin Exp Dermatol; 2018 Jul; 43(5):536-545. PubMed ID: 29356069
[TBL] [Abstract][Full Text] [Related]
22. Adipocytokine concentrations in children with different types of beta-thalassemia.
Enli Y; Balci YI; Gönen C; Uzun E; Polat A
Scand J Clin Lab Invest; 2014 Jun; 74(4):306-11. PubMed ID: 24564631
[TBL] [Abstract][Full Text] [Related]
23. Association Between Natural Killer Cell Activity and Colorectal Cancer in High-Risk Subjects Undergoing Colonoscopy.
Jobin G; Rodriguez-Suarez R; Betito K
Gastroenterology; 2017 Oct; 153(4):980-987. PubMed ID: 28625834
[TBL] [Abstract][Full Text] [Related]
24. Circulating levels of adiponectin, leptin, resistin and visfatin in non-diabetics patients with hidradenitis suppurativa.
González-López MA; Vilanova I; Ocejo-Viñals G; Arlegui R; Navarro I; Guiral S; Mata C; Pérez-Paredes MG; Portilla V; Corrales A; González-Vela MC; González-Gay MA; Blanco R; Hernández JL
Arch Dermatol Res; 2020 Oct; 312(8):595-600. PubMed ID: 31786710
[TBL] [Abstract][Full Text] [Related]
25. Serum adipokine levels in patients with ankylosing spondylitis and their relationship to clinical parameters and radiographic spinal progression.
Syrbe U; Callhoff J; Conrad K; Poddubnyy D; Haibel H; Junker S; Frommer KW; Müller-Ladner U; Neumann E; Sieper J
Arthritis Rheumatol; 2015 Mar; 67(3):678-85. PubMed ID: 25417763
[TBL] [Abstract][Full Text] [Related]
26. CA11-19: a tumor marker for the detection of colorectal cancer.
Overholt BF; Wheeler DJ; Jordan T; Fritsche HA
Gastrointest Endosc; 2016 Mar; 83(3):545-51. PubMed ID: 26318832
[TBL] [Abstract][Full Text] [Related]
27. Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients.
Kumor A; Daniel P; Pietruczuk M; Małecka-Panas E
Int J Colorectal Dis; 2009 Mar; 24(3):275-81. PubMed ID: 18979105
[TBL] [Abstract][Full Text] [Related]
28. LGALS4, CEACAM6, TSPAN8, and COL1A2: Blood Markers for Colorectal Cancer-Validation in a Cohort of Subjects With Positive Fecal Immunochemical Test Result.
Rodia MT; Solmi R; Pasini F; Nardi E; Mattei G; Ugolini G; Ricciardiello L; Strippoli P; Miglio R; Lauriola M
Clin Colorectal Cancer; 2018 Jun; 17(2):e217-e228. PubMed ID: 29352642
[TBL] [Abstract][Full Text] [Related]
29. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis.
Otero M; Lago R; Gomez R; Lago F; Dieguez C; Gómez-Reino JJ; Gualillo O
Ann Rheum Dis; 2006 Sep; 65(9):1198-201. PubMed ID: 16414972
[TBL] [Abstract][Full Text] [Related]
30. Novel serum nucleosomics biomarkers for the detection of colorectal cancer.
Holdenrieder S; Dharuman Y; Standop J; Trimpop N; Herzog M; Hettwer K; Simon K; Uhlig S; Micallef J
Anticancer Res; 2014 May; 34(5):2357-62. PubMed ID: 24778043
[TBL] [Abstract][Full Text] [Related]
31. Admission visfatin levels predict pancreatic and peripancreatic necrosis in acute pancreatitis and correlate with clinical severity.
Schäffler A; Hamer OW; Dickopf J; Goetz A; Landfried K; Voelk M; Herfarth H; Kopp A; Buechler C; Schölmerich J; Brünnler T
Am J Gastroenterol; 2011 May; 106(5):957-67. PubMed ID: 21245835
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic value of resistin and visfatin, in comparison with C-reactive protein, procalcitonin and interleukin-6 in neonatal sepsis.
Cekmez F; Canpolat FE; Cetinkaya M; Aydinöz S; Aydemir G; Karademir F; Ipcioglu OM; Sarici SÜ
Eur Cytokine Netw; 2011 Jun; 22(2):113-7. PubMed ID: 21636351
[TBL] [Abstract][Full Text] [Related]
33. Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer.
Nakajima TE; Yamada Y; Hamano T; Furuta K; Gotoda T; Katai H; Kato K; Hamaguchi T; Shimada Y
J Gastroenterol; 2009; 44(7):685-90. PubMed ID: 19430715
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
Zhang SY; Lin M; Zhang HB
Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
[TBL] [Abstract][Full Text] [Related]
35. Combined identification of long non-coding RNA CCAT1 and HOTAIR in serum as an effective screening for colorectal carcinoma.
Zhao W; Song M; Zhang J; Kuerban M; Wang H
Int J Clin Exp Pathol; 2015; 8(11):14131-40. PubMed ID: 26823726
[TBL] [Abstract][Full Text] [Related]
36. Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma.
Sun Y; Zhu S; Wu Z; Huang Y; Liu C; Tang S; Wei L
Oncotarget; 2017 Apr; 8(14):23427-23435. PubMed ID: 28178643
[TBL] [Abstract][Full Text] [Related]
37. Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease.
Valentini L; Wirth EK; Schweizer U; Hengstermann S; Schaper L; Koernicke T; Dietz E; Norman K; Buning C; Winklhofer-Roob BM; Lochs H; Ockenga J
Nutrition; 2009 Feb; 25(2):172-81. PubMed ID: 18849144
[TBL] [Abstract][Full Text] [Related]
38. A pilot study of new promising non-coding RNA diagnostic biomarkers for early-stage colorectal cancers.
Liu H; Ye D; Chen A; Tan D; Zhang W; Jiang W; Wang M; Zhang X
Clin Chem Lab Med; 2019 Jun; 57(7):1073-1083. PubMed ID: 30978169
[TBL] [Abstract][Full Text] [Related]
39. Serum Expression of
Li S; Huang M; Liu Q; Wang D; Wu R; Zhang X; Chen W; Duan L
Dis Markers; 2019; 2019():5070524. PubMed ID: 31781302
[TBL] [Abstract][Full Text] [Related]
40. The relationship between serum adiponectin and resistin levels, insulin resistance and colorectal adenomas.
Demir N; Ahıshalı E; Dolapçıoğlu C; Ercan Ş; Orçun Kaptanağası A; Dabak R; Yücel N; Sargın M; Uygur Bayramiçli O
Turk J Gastroenterol; 2015 Jan; 26(1):20-4. PubMed ID: 25698266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
